In this review, we summarise the latest findings regarding LSD1 and LSD2 in cancers of the gastrointestinal system: gastric cancer (GC), liver cancer, pancreatic cancer, and colorectal cancer (CRC). This evidence concerns the gene KDM1A and colorectal carcinoma.